| Anthony Michael Schlake, MD | |
|
935 State Farm Road, Boone, NC 28607 | |
| (859) 323-5871 | |
| Not Available |
| Full Name | Anthony Michael Schlake |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 17 Years |
| Location | 935 State Farm Road, Boone, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932362852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 2012-02087 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Watauga Medical Center | Boone, NC | Hospital |
| Charles A Cannon Jr Memorial Hospital | Linville, NC | Hospital |
| North Carolina Baptist Hospital | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Stone Center Pllc | 2961315718 | 61 |
| Appalachian Regional Medical Associates Inc | 5799877817 | 83 |
News Archive
When Tanner Martin, 17, developed excruciating back pain last year, he was sure he needed an X-ray to find out what was wrong…But Konnie Martin was no ordinary parent. As chief executive officer of San Luis Valley Regional Medical Center in Alamosa, Colorado, she is at the center of an experiment, known as value-based insurance, that could transform American healthcare.
In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.
Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
The U.N. Office on Drugs and Crime (UNODC) on Wednesday released a report - "Addiction, Crime and Insurgency: The Transnational Threat of Afghan Opium" - documenting how "[t]he smuggling of Afghan opiates is fueling addiction and drug use along trafficking routes from Iran to Central Asia," and contributing to the spread of diseases, the Associated Press reports (Oleksyn, 10/21).
› Verified 7 days ago
| Entity Name | Piedmont Stone Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700827409 PECOS PAC ID: 2961315718 Enrollment ID: O20031107000688 |
News Archive
When Tanner Martin, 17, developed excruciating back pain last year, he was sure he needed an X-ray to find out what was wrong…But Konnie Martin was no ordinary parent. As chief executive officer of San Luis Valley Regional Medical Center in Alamosa, Colorado, she is at the center of an experiment, known as value-based insurance, that could transform American healthcare.
In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.
Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
The U.N. Office on Drugs and Crime (UNODC) on Wednesday released a report - "Addiction, Crime and Insurgency: The Transnational Threat of Afghan Opium" - documenting how "[t]he smuggling of Afghan opiates is fueling addiction and drug use along trafficking routes from Iran to Central Asia," and contributing to the spread of diseases, the Associated Press reports (Oleksyn, 10/21).
› Verified 7 days ago
| Entity Name | Appalachian Regional Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669533923 PECOS PAC ID: 5799877817 Enrollment ID: O20070822000932 |
News Archive
When Tanner Martin, 17, developed excruciating back pain last year, he was sure he needed an X-ray to find out what was wrong…But Konnie Martin was no ordinary parent. As chief executive officer of San Luis Valley Regional Medical Center in Alamosa, Colorado, she is at the center of an experiment, known as value-based insurance, that could transform American healthcare.
In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.
Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
The U.N. Office on Drugs and Crime (UNODC) on Wednesday released a report - "Addiction, Crime and Insurgency: The Transnational Threat of Afghan Opium" - documenting how "[t]he smuggling of Afghan opiates is fueling addiction and drug use along trafficking routes from Iran to Central Asia," and contributing to the spread of diseases, the Associated Press reports (Oleksyn, 10/21).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Michael Schlake, MD 935 State Farm Road, Boone, NC 28607 Ph: (828) 264-5150 | Anthony Michael Schlake, MD 935 State Farm Road, Boone, NC 28607 Ph: (859) 323-5871 |
News Archive
When Tanner Martin, 17, developed excruciating back pain last year, he was sure he needed an X-ray to find out what was wrong…But Konnie Martin was no ordinary parent. As chief executive officer of San Luis Valley Regional Medical Center in Alamosa, Colorado, she is at the center of an experiment, known as value-based insurance, that could transform American healthcare.
In contrast to previous preliminary data, use of vitamin E or the diabetes drug metformin was not superior to placebo on a measured outcome for treating nonalcoholic fatty liver disease in children and adolescents, according to a study in the April 27 issue of JAMA.
Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
The U.N. Office on Drugs and Crime (UNODC) on Wednesday released a report - "Addiction, Crime and Insurgency: The Transnational Threat of Afghan Opium" - documenting how "[t]he smuggling of Afghan opiates is fueling addiction and drug use along trafficking routes from Iran to Central Asia," and contributing to the spread of diseases, the Associated Press reports (Oleksyn, 10/21).
› Verified 7 days ago
Dr. James Lawrence Hamby, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 935 State Farm Rd, Boone, NC 28607 Phone: 828-264-5150 Fax: 828-265-3611 | |
Dr. Charles Miller, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 935 State Farm Rd, Boone, NC 28607 Phone: 828-264-5150 Fax: 828-265-3611 |